Georgia Urology P.A. — research payments reported

By program year

4 rows

Year	Kind	Amount	Payments
2024	Research	$12,755	1
2023	Research	$4,512	8
2022	Research	$6,392	4
2021	Research	$1,063	3

Breakdown

Who paid Research payments · program years 2021–2024

Axonics Modulation Technologies, Inc. $13,818 4 payments
Urovant Sciences Inc $6,392 4 payments
Sumitomo Pharma America, Inc. $4,512 8 payments

Studies the money was for Research payments · program years 2021–2024

Foramen Finder Study $12,755 1 payment
Composur, A Patient-centric, Phase IV, Open-label, Prospective, Real World US Study to Evaluate Vibegron on Patient Treatment Satisfaction, Quality of Life, and Healthcare Resource Utilization in Overactive Bladder $7,452 6 payments
A Patient-centric, Phase IV, Open-label, Prospective, Real World US Study to Evaluate Vibegron on Patient Treatment Satisfaction, Quality of Life, and Healthcare Resource Utilization in Overactive Bladder $3,452 6 payments
Artistry $1,063 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.